$4.46
In chiusura: Oct 2 EDT
$4.48
0.030.56%
Pre-mercato: 6:59 AM EDT
Unicycive Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Unicycive Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
UNCY | Unicycive Therapeutics | -$0.50 | -$0.95 | — | — | $0.00 | $265.62K | — | — | 11/12/2025 | |
UNCY | Unicycive Therapeutics | -$1.50 | -$0.70 | -$0.52 | 25.71% | $0.00 | — | $0.00 | — | 08/14/2025 | |
UNCY | Unicycive Therapeutics | -$6.10 | -$0.70 | -$0.50 | 28.57% | $675.00K | — | $0.00 | — | 05/14/2025 | |
UNCY | Unicycive Therapeutics | -$3.50 | -$0.70 | -$2.60 | -271.43% | $0.00 | — | $0.00 | — | 03/31/2025 | |
UNCY | Unicycive Therapeutics | -$1.30 | -$1.50 | -$0.50 | 66.67% | $951.00K | — | $0.00 | — | 11/13/2024 | |
UNCY | Unicycive Therapeutics | -$2.90 | -$1.90 | -$1.50 | 21.05% | $0.00 | — | $0.00 | — | 08/14/2024 | |
UNCY | Unicycive Therapeutics | -$2.90 | -$1.50 | -$6.10 | -306.67% | $0.00 | — | $675.00K | — | 05/13/2024 | |
UNCY | Unicycive Therapeutics | -$5.10 | -$1.70 | -$2.20 | -29.41% | $0.00 | — | $0.00 | — | 03/28/2024 | |
UNCY | Unicycive Therapeutics | -$3.70 | -$1.20 | -$3.70 | -208.33% | $0.00 | — | $951.00K | — | 11/14/2023 | |
UNCY | Unicycive Therapeutics | -$2.40 | -$3.40 | -$2.90 | 14.71% | $0.00 | — | $0.00 | — | 08/14/2023 | |
UNCY | Unicycive Therapeutics | -$2.40 | -$3.70 | -$2.90 | 21.62% | $0.00 | $370.00K | $0.00 | -100.00% | 05/16/2023 | |
UNCY | Unicycive Therapeutics | -$1.70 | -$2.40 | -$5.10 | -112.50% | $0.00 | — | $0.00 | — | 03/31/2023 | |
UNCY | Unicycive Therapeutics | -$3.70 | -$2.80 | -$3.70 | -32.14% | $0.00 | — | $0.00 | — | 11/14/2022 | |
UNCY | Unicycive Therapeutics | -$1.30 | -$2.30 | -$2.40 | -4.35% | $0.00 | — | $0.00 | — | 08/15/2022 | |
UNCY | Unicycive Therapeutics | -$1.10 | -$1.60 | -$2.40 | -50.00% | $0.00 | — | $0.00 | — | 05/12/2022 | |
UNCY | Unicycive Therapeutics | — | -$1.30 | -$1.70 | -30.77% | — | — | $0.00 | — | 03/31/2022 | |
UNCY | Unicycive Therapeutics | -$0.80 | -$1.00 | -$3.40 | -240.00% | $0.00 | — | $0.00 | — | 11/11/2021 | |
UNCY | Unicycive Therapeutics | -$0.40 | — | -$1.30 | — | $0.00 | — | $0.00 | — | 08/16/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-14 | $-0.52 | $-0.70 | 25.7 % |
Q1 | 2025-05-14 | $-0.50 | $-0.70 | 28.6 % |
Q4 | 2025-03-31 | $-2.60 | $-0.70 | -271.4 % |
Q3 | 2024-11-13 | $-0.50 | $-1.50 | 66.7 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q1 | 2023-05-16 | $0 | $370.00K | -100.0 % |
Si prevede che Unicycive Therapeutics (UNCY) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
L'EPS effettivo era $-0.52, che superato la stima di $-0.70.
Le entrate effettive sono state $0K, che centrato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.